
Ryan Dusick on Humor & Healing
This episode is for anyone who has ever felt alone in their struggle. We sit down with the incredible Aleksei Archer—comedian, actor, and mental health…
Thought Leader: Ryan Dusick
By Scott Gottlieb (Original source Modern Healthcare)
“Dr. Scott Gottlieb has taken industry skeptics by surprise.
When the Trump administration tapped Gottlieb to lead the U.S. Food and Drug Administration last year, branded-drug manufacturers and their investors celebrated. Others were less exuberant.
Industry observers expected Gottlieb, who advised GlaxoSmithKline and was a board member for several other drug and device makers, to protect Big Pharma’s interests.
Yet, about a year later, the FDA commissioner has quieted many of his critics. An unprecedented level of transparency and public disclosure has garnered support from across the industry. Gottlieb has tried to curb drug prices by introducing more generics. The public health community praised his policies that look to lower salt content in food and nicotine in cigarettes, as well as crack down on opioid distributors and websites.”
Click here to see more
Ryan Dusick on Humor & Healing
This episode is for anyone who has ever felt alone in their struggle. We sit down with the incredible Aleksei Archer—comedian, actor, and mental health…
Thought Leader: Ryan Dusick
Peter Zeihan: Ukraine Hammers Russian Oil Infrastructure
The Ukrainians have ramped up strikes on Russian energy infrastructure, sending ripples through Russia’s refining capacity and triggering fuel shortages. But what changes enabled this…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta Explores Everyday Health Habits
Diffusers, with their different scents, are meant to create a mood and relax you. But is it healthy to breathe in mist enhanced by essential…
Thought Leader: Sanjay Gupta